How many institutions held BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in Q4 2021?

90 institutional investors reported BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 for Q4 2021. Use the holders table for investor-level position and value details.

BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)

Q: What does CUSIP 09075P105 represent in this 13F holders report?

CUSIP 09075P105 is the security identifier for BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 used to aggregate holder disclosures.

CUSIP: 09075P105

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.001
Shares outstanding: 26,011,000
Total 13F shares: 13,927,053
Share change: +1,091,996
Total reported value: $283,060,517
Put/Call ratio: 84%
Price per share: $20.33
Number of holders: 90
Value change: +$19,228,913
Number of buys: 47
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 09075P105?
CUSIP 09075P105 identifies BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 09075P105:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BioXcel Holdings, Inc.	3/4/5	10%+ Owner	— class O/S missing	8,546,750	$187,088,358	—	25 Jun 2021	3/4/5
BioXcel LLC	3/4/5	10%+ Owner	— class O/S missing	8,546,750	$187,088,358	—	25 Jun 2021	3/4/5
FMR LLC	13F	Company	15%	3,785,384	$114,887,000	—	30 Sep 2021	13F
Artemis Investment Management LLP	13F	Company	5.3%	1,380,260	$41,892,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	5.1%	1,328,599	$40,323,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	4.7%	1,216,737	$36,928,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	3.9%	1,020,255	$30,965,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	3.7%	967,920	$29,376,000	—	30 Sep 2021	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	1.6%	417,510	$12,671,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	297,039	$9,015,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.92%	239,224	$7,260,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0.83%	215,725	$6,548,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.73%	190,098	$5,770,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.5%	129,964	$3,945,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.46%	120,733	$3,664,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.24%	63,708	$1,933,000	—	30 Sep 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.23%	59,803	$1,815,000	—	30 Sep 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.23%	59,344	$1,801,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.21%	54,171	$1,645,000	—	30 Sep 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.2%	51,221	$1,555,000	—	30 Sep 2021	13F
ACT CAPITAL MANAGEMENT, LLC	13F	Company	0.19%	50,000	$1,518,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	46,527	$1,428,000	—	30 Sep 2021	13F
BAILARD, INC.	13F	Company	0.18%	46,000	$1,396,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.16%	42,400	$1,287,000	—	30 Sep 2021	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.15%	40,000	$1,214,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.15%	39,362	$1,195,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.14%	37,300	$1,132,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	35,969	$1,091,000	—	30 Sep 2021	13F
AlphaCentric Advisors LLC	13F	Company	0.13%	35,000	$1,062,000	—	30 Sep 2021	13F
Hudson Bay Capital Management LP	13F	Company	0.13%	35,000	$1,062,000	—	30 Sep 2021	13F
ALPS ADVISORS INC	13F	Company	0.13%	34,278	$1,040,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.13%	33,110	$1,005,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	32,894	$999,000	—	30 Sep 2021	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.12%	32,344	$982,000	—	30 Sep 2021	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.12%	30,086	$913,000	—	30 Sep 2021	13F
CSS LLC/IL	13F	Company	0.1%	25,727	$781,000	—	30 Sep 2021	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.1%	25,273	$767,036	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	25,198	$765,000	—	30 Sep 2021	13F
Altshuler Shaham Ltd	13F	Company	0.09%	24,369	$744,000	—	30 Sep 2021	13F
DAVENPORT & Co LLC	13F	Company	0.09%	22,570	$685,000	—	30 Sep 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.08%	21,514	$652,950	—	30 Sep 2021	13F
Ghisallo Capital Management LLC	13F	Company	0.08%	20,000	$607,000	—	30 Sep 2021	13F
Knoll Capital Management, LLC	13F	Company	0.08%	20,000	$607,000	—	30 Sep 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.07%	19,087	$579,000	—	30 Sep 2021	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.07%	18,200	$552,000	—	30 Sep 2021	13F
Lido Advisors, LLC	13F	Company	0.06%	16,643	$505,000	—	30 Sep 2021	13F
HITE Hedge Asset Management LLC	13F	Company	0.06%	16,397	$498,000	—	30 Sep 2021	13F
Capital Investment Advisory Services, LLC	13F	Company	0.06%	16,175	$491,000	—	30 Sep 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0.06%	15,322	$465,000	—	30 Sep 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	15,312	$465,000	—	30 Sep 2021	13F

Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q4 2021

As of 31 Dec 2021, BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,927,053 shares. The largest 10 holders included FMR LLC, ALLIANCEBERNSTEIN L.P., Artemis Investment Management LLP, STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and UBS Group AG. This page lists 90 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

103

Q4 2021 holders

Holder diff

-13

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.